Celon Pharma at Jefferies Virtual London Healthcare Conference

The Company’s representatives will take part in the largest pharmaceutical conference in Europe. Maciej Wieczorek, CEO of Celon Pharma S.A.: We are increasing the presence of our products abroad, building a strong position in the segment of inhalation products on the global pharmaceutical market; we are observing that companies from around the world are takingRead more »

The experts agree. The targeted drug against COVID currently developed by Celon Pharma might change the course of the disease.

Thanks to its cutting-edge, innovative approach, Celon Pharma fast-tracks confirmation of the efficacy of its treatment against SARS-COV-2. The new therapeutic approach designed by scientists at Celon Pharma combines the previously dispersed possible responses to the threat brought about by SARS-COV-2. That approach assumes shortening of the infection duration in affected patients and significant limitationRead more »

Celon Pharma at the GPW Innovation Day 2020

The GPW Innovation Day is a free-access conference during which representatives of companies operating in the field of new technologies, games or biotechnology meet with stock investors. This year, it will be held on-line on 23 and 24 June 2020. In the previous edition of the conference, the company presentations were participated by over 300Read more »

Celon Pharma at BIO Digital 2020

Company representatives will participate  in one of the largest partnering conferences for the biopharmaceutical industry, which will be held on 8-11.06.2020. During online sessions they will present selected projects in the therapeutic areas such as: neuropsychiatry, inflammatory and metabolic diseases. If you are interested in meeting with the Company, please contact: [email protected] More information aboutRead more »

The largest and most advanced innovative pipeline in Poland with the potential for global commercialisation, supported by a favourable domestic and worldwide dynamic of product sales.

Net profit of over PLN 9.4 million in Q1 2020, increase in domestic sales by 16% and by 2% in export sales, compared to the same period in 2019. In the first quarter of 2020, the value of sales revenues amounted to PLN 30.9 million. It included the product sales in Poland, which accounted forRead more »